Reactogenicity and safety of a liquid human rotavirus vaccine (RIX4414) in healthy adults, children and infants in China: Randomized, double-blind, placebo-controlled Phase I studies

Lignende værker

• Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants
  af: Li, Rong-cheng, et al.
  Udgivet: (2015)
• Post-marketing safety surveillance conducted in Korea (2008–2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™)
  af: Shin, Son Moon, et al.
  Udgivet: (2016)
• Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China
  af: Li, Rong-cheng, et al.
  Udgivet: (2014)
• Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
  af: Cunliffe, Nigel, et al.
  Udgivet: (2014)
• The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
  af: Buyse, Hubert, et al.
  Udgivet: (2014)